SPY766.62−0.02%QQQ689.02−0.42%BTC/USD80,300.01−0.16%DIA534.30+0.22%GLD374.79+0.62%TLT81.92+0.20%

Premium Services

SCYNEXIS Inc

SCYXNASDAQ

Trade with Public

Trade with Public

$3.84

-0.10-2.54%

Last update: Nov 4, 4:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

SCYNEXIS (SCYX) Stock Price Target 2026

The average analyst price target for SCYNEXIS is $33, 725.0% above the current price. Of 2 analysts, 2 rate it Buy. The latest change came on Aug 13, 2026, when Guggenheim raised its price target on SCYNEXIS from $24 to $33 and kept a Buy rating.

The Average Analyst Price Target for SCYNEXIS is $33.

Price Target Range — 2 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$33Upside to Avg. PT+725.0%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for SCYNEXIS Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 13, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$24→$33
Oct 28, 2025	Guggenheim	Vamil Divan	PT Cut	Buy	$32→$24
Apr 1, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—

Analyst Ratings News

PRO
Guggenheim Maintains Buy on SCYNEXIS, Raises Price Target to $33

Guggenheim analyst Vamil Divan maintains SCYNEXIS (NASDAQ:SCYX) with a Buy and raises the price target from $24 to $33.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on SCYNEXIS, Lowers Price Target to $3

Guggenheim analyst Vamil Divan maintains SCYNEXIS (NASDAQ:SCYX) with a Buy and lowers the price target from $4 to $3.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on SCYNEXIS

Cantor Fitzgerald analyst Louise Chen reiterates SCYNEXIS (NASDAQ:SCYX) with a Overweight.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on SCYNEXIS, Maintains $15 Price Target

Cantor Fitzgerald analyst Louise Chen reiterates SCYNEXIS (NASDAQ:SCYX) with a Overweight and maintains $15 price target.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on SCYNEXIS, Raises Price Target to $9

Guggenheim analyst Vamil Divan maintains SCYNEXIS (NASDAQ:SCYX) with a Buy and raises the price target from $8 to $9.

Benzinga Newsdesk

PRO
Ladenburg Thalmann Reiterates Buy on SCYNEXIS, Maintains $15 Price Target

Ladenburg Thalmann analyst Michael Higgins reiterates SCYNEXIS (NASDAQ:SCYX) with a Buy and maintains $15 price target.

Benzinga Newsdesk